Parham HADDADI in

Parham HADDADI

Sharpshooter · DISC type DC
"Head of AI-Bio_ Associate Director" @ AstraZeneca-Alexion at Alexion Pharmaceuticals, Inc.
📍 Boston, Massachusetts, United States

Parham Haddadi is the Head of AI-Bio and Associate Director at AstraZeneca-Alexion, focusing on rare diseases. With a Ph. D. in Molecular Genetics, he has over 20 years of experience leading computational biology and data science initiatives in human, plant, and microbial genetics to drive therapeutic innovation.

He has a keen interest in leveraging AI and machine learning for drug discovery, including target identification and drug repurposing. His work also involves structural biology and analyzing diverse biological data types like genomics, proteomics, and transcriptomics to extract meaningful insights for developing new treatments.

Unique fact: Before focusing on human rare diseases, he led government-funded research projects in Canada focusing on agricultural genomics, specifically for canola.

Read the full overview →
Experience
7 Years
Current Role
"Head of AI-Bio_ Associate Director" @ AstraZeneca-Alexion
Job Level
Mid-senior
Location
Boston, Massachusetts, United States
Personality Overview

How Parham shows up

Precise But Practical
ROI Driven
Thorough Evaluator

They do not care very much about building rapport or relationships. They like to stay in control of the negotiation or defining of the terms. They are less concerned about the product and more about its potential impact.

Priorities

Topics Parham cares about

AI in Drug Discovery
Leads initiatives in AI-powered small molecule and AAV capsid engineering, and multi-omics based biomarker discovery at AstraZeneca-Alexion.
Rare Disease Research
His current role is centered on applying computational biology and AI to find treatments for rare diseases. Co-authored a 2024 paper on a foundation model for rare diseases.
+5 more topics Login to view topics
Career

Work history

11-2025
"Head of AI-Bio_ Associate Director" @ AstraZeneca-Alexion
Alexion Pharmaceuticals, Inc.
5-2025
Head of AI-Bio & Structural biology | Team Lead
Alexion Pharmaceuticals, Inc.
3-2024 - 4-2025
Principal Bioinformatics Scientist
Alexion Pharmaceuticals, Inc.
9-2022 - 11-2023
Senior CB
Homology Medicines, Inc.
9-2017 - 8-2022
Leadership| Bioinformatics| Computational Biology| NGS| Multiomics|
Agriculture and Agri-Food Canada
In the press

Media appearances

No media yetWe could not find public media appearances for this person.
Education
2005 - 2010
Doctor of Philosophy - PhD2
Toulouse INP
Doctor of Philosophy - PhD1
University of Tehran
Social presence
in
Behavioral profile

DISC profile (public)

D

Dominance (D)

Dominance (D) reflects how goal and task oriented a person is, and their ability to accomplish results irrespective of how demanding the circumstances might be. Those scoring high tend to be motivated by winning, competition, and success.

Other Alexion Pharmaceuticals, Inc. Employees

Explore more public profiles from related professionals.

More profiles

Discover additional public profiles from our index.

Unlock the full playbookSee exactly how to sell to Parham. Free, 10 seconds.